A logo is pictured on the World Health Organization (WHO) headquarters in Geneva, Switzerland.

WHO backs rollout of first approved malaria vaccine

Malaria is far more deadly than COVID-19 in Africa. It killed 386,000 Africans in 2019, according to a WHO estimate, compared with 212,000 confirmed deaths from COVID-19 in the past 18 months.

A doctor tests a child for malaria at the Ithani-Asheri Hospital in Arusha, Tanzania

BioNTech aims to develop mRNA-based malaria vaccine

A German company, Biontech, is currently developing a vaccine for malaria based on COVID-19 vaccine technology.


Israeli start-up wins grand prize for app looking to combat malaria

Israel-based Zzapp Malaria has won the grand prize of $3 million in the $5M IBM Watson AI XPRIZE Challenge for their artificial intelligence-informed platform that identifies malaria hotspots.

Jerusalem start-up looks to help eliminate malaria in Africa

Malaria kills more than 400,000 people yearly, most of whom are children under the age of five, and greatly impedes developing economies.


ZzappMalaria – The new app that can beat back malaria-bearing mosquitos

The app is designed to work even in environments where the Internet is not always available, as well as on low-cost phones.

Newly elected Director-General of the World Health Organization (WHO) Tedros Adhanom Ghebreyesus att

WHO report reviews 10 years of anti-malarial drug resistance

Because of the small amount of available treatments, anti-malarial drug resistance is a significant threat.


Malaria patient admitted to Galilee Medical Center in critical condition

The man was suffering from high fever and confusion * He told medical staff that he recently visited an African country.


Scientists map out mosquito immune system to help fight malaria

Malaria affects more than 200 million people worldwide and killed an estimated 405,000 people in 2018 - most of them babies and children under five years old.


Study predicts surge in HIV, TB and malaria deaths amid COVID-19 pandemic

The United Nations AIDS agency and the WHO warned last week of stock shortages, with more than a third of the world's countries already saying they are at risk of running of antiretrovirals.


WHO halts trial of hydroxychloroquine in COVID-19 patients

"After deliberation, they have concluded that the hydroxychloroquine arm will be stopped from the Solidarity Trial," Henao-Restrepo told a media briefing.

Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy